Engineers Gate Manager LP Halozyme Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 12,824 shares of HALO stock, worth $799,191. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,824

Previous 29,368 56.33%

Holding current value

$799,191

Previous $1.4 Million 41.74%

% of portfolio

0.01%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$47.74 - $65.16 $789,810 - $1.08 Million	-16,544 Reduced 56.33%	12,824 $818,000
Q4 2024 Feb 14, 2025	SELL	$42.57 - $61.09 $1.18 Million - $1.69 Million	-27,724 Reduced 48.56%	29,368 $1.4 Million
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $2.5 Million - $3.15 Million	48,824 Added 590.52%	57,092 $3.27 Million
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $963,965 - $1.34 Million	-25,495 Reduced 75.51%	8,268 $432,000
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $1.75 Million - $2.18 Million	-51,874 Reduced 60.57%	33,763 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $424,963 - $536,943	12,754 Added 17.5%	85,637 $3.17 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $1.98 Million - $2.4 Million	54,439 Added 295.16%	72,883 $2.78 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $732,109 - $936,655	-24,178 Reduced 56.73%	18,444 $665,000
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $1.4 Million - $2.37 Million	42,622 New	42,622 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $830,365 - $1.07 Million	22,232 New	22,232 $978,000
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $442,776 - $584,934	-11,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $82,931 - $107,993	2,099 Added 22.57%	11,400 $475,000
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $289,046 - $488,500	-11,199 Reduced 54.63%	9,301 $397,000
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $208,494 - $240,003	8,100 Added 65.32%	20,500 $539,000
Q2 2020 Aug 17, 2020	BUY	$16.25 - $26.81 $201,500 - $332,444	12,400 New	12,400 $332,000

Others Institutions Holding HALO

# of Institutions

584

Shares Held

122M

Call Options Held

308K

Put Options Held

186K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.68B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Halozyme Therapeutics, Inc. Transaction History